NCI is the nation's leader in cancer research
Post comments, ask questions, and share information with RAS experts.
Researchers are studying whether less intense treatment can be safer but still effective.
NCI is mobilizing its experts and resources to study COVID-19.
Learn how CCDI is working to increase data use and sharing to improve outcomes for young people with cancer.
NCI's RAS Initiative explores innovative approaches for attacking the proteins encoded by mutant forms of the KRAS gene.
